Cargando…
The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents
Obesity is a global epidemic associated with significant morbidity and mortality in adults and ill health in children. A proven successful approach in weight management has been the disruption of nutrient digestion, with orlistat having been used to treat obesity for the last 10 years. Although orli...
Autores principales: | Tucci, Sonia A, Boyland, Emma J, Halford, Jason CG |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047983/ https://www.ncbi.nlm.nih.gov/pubmed/21437083 |
Ejemplares similares
-
Stigmatisation of a Formerly Obese Young Female
por: Tucci, Sonia A., et al.
Publicado: (2013) -
The inhibitory activity of herbal medicines on the keys enzymes and steps related to carbohydrate and lipid digestion
por: Sompong, Weerachat, et al.
Publicado: (2016) -
Inequalities in the uptake of weight management interventions in a pragmatic trial: an observational study in primary care
por: Ahern, Amy L, et al.
Publicado: (2016) -
Preventive obesity agent montmorillonite adsorbs dietary lipids and enhances lipid excretion from the digestive tract
por: Xu, Pengfei, et al.
Publicado: (2016) -
The Health Halo Trend in UK Television Food Advertising Viewed by Children: The Rise of Implicit and Explicit Health Messaging in the Promotion of Unhealthy Foods
por: Whalen, Rosa, et al.
Publicado: (2018)